# Chemed Corp: Form 10-Q for the period ended Jun 30, 2010

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-Q
- Filed: 2010-07-30
- Accepted by EDGAR: Jul 30, 2010, 15:48 ET
- Period: 2010-06-30
- Accession: 0001157523-10-004512
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752310004512/a6371735.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752310004512/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2010-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2010-04-01 to 2010-06-30 | $315.0m | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2010-01-01 to 2010-06-30 | $623.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2010-04-01 to 2010-06-30 | $223.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2010-01-01 to 2010-06-30 | $442.8m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2010-04-01 to 2010-06-30 | $50.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2010-01-01 to 2010-06-30 | $98.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2010-04-01 to 2010-06-30 | $33.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2010-01-01 to 2010-06-30 | $68.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2010-04-01 to 2010-06-30 | $3.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2010-01-01 to 2010-06-30 | $6.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2010-04-01 to 2010-06-30 | $12.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2010-01-01 to 2010-06-30 | $24.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2010-04-01 to 2010-06-30 | $18.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2010-01-01 to 2010-06-30 | $38.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2010-04-01 to 2010-06-30 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2010-01-01 to 2010-06-30 | $1.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2010-04-01 to 2010-06-30 | $0.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2010-01-01 to 2010-06-30 | $1.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2010-04-01 to 2010-06-30 | 23,080,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2010-01-01 to 2010-06-30 | 23,012,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2010-01-01 to 2010-06-30 | $20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2010-01-01 to 2010-06-30 | $11.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2010-01-01 to 2010-06-30 | $5.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2010-01-01 to 2010-06-30 | $10.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2010-06-30 | $109.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2010-06-30 | $244.0m | us-gaap:AssetsCurrent |
| Total assets | at 2010-06-30 | $866.0m | us-gaap:Assets |
| Current liabilities | at 2010-06-30 | $141.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2010-06-30 | $353.0m | us-gaap:Liabilities |
| Long-term debt | at 2010-06-30 | $155.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2010-06-30 | $513.0m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2010-06-30 | 22,787,983 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752310004512/a6371735.htm

Filed Jul 30, 2010.
Source: SEC EDGAR, the filing index for accession 0001157523-10-004512. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
